These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11744564)
1. The impact of new drugs on management of glaucoma in Scotland: observational study. Bateman DN; Clark R; Azuara-Blanco A; Bain M; Forrest J BMJ; 2001 Dec; 323(7326):1401-2. PubMed ID: 11744564 [No Abstract] [Full Text] [Related]
2. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost]. Gebhardt DO Ned Tijdschr Geneeskd; 1999 Jan; 143(5):275. PubMed ID: 10086159 [No Abstract] [Full Text] [Related]
3. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Bateman DN; Clark R; Azuara-Blanco A; Bain M; Forrest J Br J Ophthalmol; 2002 May; 86(5):551-4. PubMed ID: 11973253 [TBL] [Abstract][Full Text] [Related]
4. Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017. Yu L; Ding K; Luo L; Yu Z PLoS One; 2020; 15(1):e0227595. PubMed ID: 31929565 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological advances in the treatment of glaucoma. Serle JB Drugs Aging; 1994 Sep; 5(3):156-70. PubMed ID: 7803944 [TBL] [Abstract][Full Text] [Related]
6. New medical therapies in glaucoma management. Skorin L J Am Osteopath Assoc; 1997 Oct; 97(10):582-3. PubMed ID: 9357230 [TBL] [Abstract][Full Text] [Related]
7. [Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost]. Hoyng PF; Rasker MT Ned Tijdschr Geneeskd; 1998 Sep; 142(39):2138-41. PubMed ID: 9856229 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it? Juncal VR; Abdo Jorge F; Paranhos A; Santos Prata T Can J Ophthalmol; 2015 Aug; 50(4):297-301. PubMed ID: 26257224 [TBL] [Abstract][Full Text] [Related]
10. Glaucoma prescribing trends in Australia and New Zealand. Carroll SC; Gaskin BJ; Goldberg I; Danesh-Meyer HV Clin Exp Ophthalmol; 2006 Apr; 34(3):213-8. PubMed ID: 16671900 [TBL] [Abstract][Full Text] [Related]
11. Prescribing Trends in a Glaucoma Clinic and Adherence to EGS Guidelines: A Retrospective, Non-Interventional, Single-Center UK Study. Fajgenbaum M; Ansari E Adv Ther; 2017 Aug; 34(8):2033-2042. PubMed ID: 28726170 [TBL] [Abstract][Full Text] [Related]
12. New drug therapies for glaucoma. Bartlett JD J Am Optom Assoc; 1996 Nov; 67(11):648-53. PubMed ID: 8979656 [No Abstract] [Full Text] [Related]
13. Prescribing Trends of Topical Glaucoma Medications in Australia From 2001 to 2017. Perera N; Pinnuck BC; Jamieson MPH; Ling D; Williams M; Chen O J Glaucoma; 2020 Mar; 29(3):175-183. PubMed ID: 31790066 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension. Stewart WC; Sharpe ED; Day DG; Kolker AE; Konstas AG; Lee WH; Rieser JC; Chopra H; Holmes KT J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922 [TBL] [Abstract][Full Text] [Related]
16. New agents in glaucoma therapy. Kooner KS Int Ophthalmol Clin; 1999; 39(3):1-15. PubMed ID: 10709570 [No Abstract] [Full Text] [Related]
17. A review of glaucoma treatment in Scotland 1994-2004. Macleod SM; Clark R; Forrest J; Bain M; Bateman N; Azuara-Blanco A Eye (Lond); 2008 Feb; 22(2):251-5. PubMed ID: 17001326 [TBL] [Abstract][Full Text] [Related]
18. Brinzolamide plus brimonidine for the treatment of glaucoma: an update. Chew SK; Skalicky SE; Goldberg I Expert Opin Pharmacother; 2014 Nov; 15(16):2461-71. PubMed ID: 25267543 [TBL] [Abstract][Full Text] [Related]
19. [Modern anti-glaucoma drugs and their secondary effects]. Mermoud A Rev Med Suisse Romande; 1998 Nov; 118(11):937-40. PubMed ID: 9865122 [No Abstract] [Full Text] [Related]
20. Changes in glaucoma medication numbers after cataract and glaucoma surgery: A nationwide population-based study. Chen HY; Lin CL; Kao CH Medicine (Baltimore); 2019 Jan; 98(4):e14128. PubMed ID: 30681574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]